Hutchens MP, Fujiyoshi T, Komers R, Herson PS, Anderson S.Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am J Physiol Renal Physiol 303: F377-F385, 2012. First published May 23, 2012 doi:10.1152/ajprenal.00354.2011.-Emerging evidence suggests that renal endothelial function may be altered in ischemia-reperfusion injury. Acute kidney injury is sexually dimorphic, and estrogen protects renal tubular function after experimental ischemic injury. This study tested the hypothesis that during ischemiareperfusion, estrogen alters glomerular endothelial function to prevent hyperpermeability. Glomerular endothelial cells were exposed to 8-h oxygen-glucose deprivation (OGD) followed by 4-and 8-h reoxygenation-glucose repletion. After 4-h reoxygenation-glucose repletion, transendothelial permeability to Ficoll-70 was reduced, and transendothelial resistance increased, by 17-estradiol vs. vehicle treatment during OGD (OGD-vehicle: 91.0 Ϯ 11.8%, OGD-estrogen: 102.6 Ϯ 10.8%, P Ͻ 0.05). This effect was reversed by coadministration of G protein-coupled receptor 30 (GPR30) antagonist G15 with 17-estradiol (OGD-estrogen-G15: 89.5 Ϯ 6.9, P Ͻ 0.05 compared with 17-estradiol). To provide preliminary confirmation of this result in vivo, Ficoll-70 was administered to mice 24 h after cardiac arrest and cardiopulmonary resuscitation (CA/CPR). Blood urea nitrogen (BUN) and serum creatinine (SCr) in these mice were elevated within 12 h following CA/CPR and reduced at 24 h by pretreatment with 17-estradiol (BUN/SCr 17-estradiol: 34 Ϯ 19/0.2 Ϯ 0.1 vehicle: 92 Ϯ 49/0.5 Ϯ 0.3, n ϭ 8 -12, P Ͻ 0.05). Glomerular sieving of Ficoll 70 was increased by CA/CPR within 2 h of injury and 17-estradiol treatment (; 17-estradiol: 0.74 Ϯ 0.26 vs. vehicle: 1.05 Ϯ 0.53, n ϭ 14 -15, P Ͻ 0.05). These results suggest that estrogen reduces postischemic glomerular endothelial hyperpermeability at least in part through GPR30 and that estrogen may regulate post CA/CPR glomerular permeability in a similar fashion in vivo.ischemia-reperfusion injury; renal ischemia; acute renal failure; acute kidney injury; oxygen-glucose deprivation; cardiac arrest; cardiopulmonary resuscitation; gender; sex; estrogen; estradiol ACUTE KIDNEY INJURY (AKI) occurs in 10 -30% of intensive care unit patients. There are few therapeutic options for this disease, which has extremely high mortality (up to 70%) and morbidity, with 10% of AKI patients progressing to dialysis-dependent end-stage renal disease (8,23,26,45,46). AKI is a sexually dimorphic disease, with both incidence and mortality being lower in women compared with men (15,30, 49). Experimental models recapitulate the sexually dimorphic nature of AKI and implicate sex steroids in the sex differences observed, demonstrating that androgens increase and estrogens decrease kidney damage in animal models. Several studies have characterized the effects of sex steroids on AKI in animal models and strongly suggested a protective effect of estrogen, but a detailed understanding ...